BS

Beena Srivastava

Active Director Director DIN 03178615
DIN 03178615 First appointment Oct 2010 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2010
Shareholding value •••• Premium profile

About Beena Srivastava

Data last updated:

Beena Srivastava is a Director at Symira Pharmaceuticals Private Limited (since 2010). The company operates in Trading. Symira Pharmaceuticals Private Limited reported revenue of ₹22.8 Lakh (FY 2025).

DIN 03178615
Primary Designation Director
Industry Trading
First Appointment 29 Oct 2010
Oldest Company Age 16 yrs
Largest company Symira Pharmaceuticals Private Limited · ₹22.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20102010₹22.8 Lakh (FY 2025)Active

Board colleagues of Beena Srivastava

Directorship timeline

Open interactive timeline →
Symira Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Beena Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Beena Srivastava

Beena Srivastava currently holds 1 directorship: Symira Pharmaceuticals Private Limited (Director, since 29 Oct 2010, revenue ₹22.8 Lakh (FY 2025)).

Beena Srivastava was first appointed on 29 Oct 2010 as Director at Symira Pharmaceuticals Private Limited.

The current boards of Beena Srivastava's companies include Rajesh Kumar (Symira Pharmaceuticals Private Limited), Sourabh Kumar Tewari (Symira Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available